Friday, 16 October 2026European Markets

LISGRAFICA Stock Surges By 33% In 21 Sessions: Is It Time To Buy?

Loading stream...

(VIANEWS) - LISGRAFICA (PSI: LIG.LS) saw its shares surge 33.33% over 21 sessions from EUR0.01 to EUR0.01 at 15:32 EST on Monday after five consecutive losses. LISGRAFICA continued its upward trajectory during Tuesday's session as its PSI rose 0.34% towards EUR6,150.98. LISGRAFICA closed at EUR0.01, 36.84% off its 52-week high of EUR0.01.

About LISGRAFICA

Lisgrafica - Impressao e Artes Graficas, S.A. is a printing company located in Agualva-Cacem, Portugal that was established in 1973. Specializing in producing magazines, newspapers, supplements, catalogs, brochures and telephone directories; Lisgrafica is owned by Rasografica - Comercio e Servicos Graficos S.A. as its subsidiary company.

Yearly Analysis

Based on available information, LISGRAFICA's stock is currently trading above its 52-week high of EUR0.01, suggesting that investors have an optimistic view on its growth potential and value its shares as investments. However, investors must remember that past performance does not guarantee future results. They should conduct further research and analysis in order to ascertain if LISGRAFICA stock offers them an attractive investment opportunity according to their individual investment goals and risk tolerance. Before making a decision to invest in LISGRAFICA stock, it may also be wise to assess other aspects such as its financial health, industry trends and overall market conditions.

Technical Analysis

Stock Movements: LISGRAFICA's Upturn Remains Stimulated LISGRAFICA, an established player in the graphics industry, has seen its stock price reach an all-time high. Investors appear optimistic about LISGRAFICA's prospects as evidenced by its current stock price of EUR1.97 which significantly outstrips both its 50-day moving average of EUR0.01 and 200-day moving average of EUR0.01. Reduce Volume and Lower Liquidity LISGRAFICA's trading volume, however, has been below expectations; today's reported volume of 8000 was 99.93% lower than its average volume of 29698 and may indicate lack of investor trust in the company's future prospects. LISGRAFICA's recent performance has been marked by increasing volatility. Over the last week, month and quarter, current intraday variation averages have averaged negative 8.33%, negative 3.57% and positive 17.37%, respectively - these levels being driven mainly by investors' reactions to announcements made and financial performance seen over this timeframe. By virtue of the Stochastic Oscillator, an established indicator for measuring overbought and oversold conditions, LISGRAFICA stock is currently considered overbought (>=80), suggesting investors may have overextended themselves and require time for correction or consolidation to fully account for potential moves forward. Lisgrafica stock price continues to trend upward, yet investors should remain wary due to low trading volume and overbought conditions. To remain on an upward path, LISGRAFICA must maintain momentum by producing consistent financial results that ensure long-term investor loyalty.

Quarter Analysis

According to the information provided, it appears that revenue growth for the quarter has experienced a year-on-year decrease of 12% - meaning revenue has decreased since same period last year and currently sits at 9.78M for twelve trailing months. As an investment expert, it is vitally important for investors to keep in mind that any decline in revenue growth may cause concern; however, other factors should also be taken into consideration such as company profitability, competitive position and overall market conditions. Furthermore, investors should research a company's growth strategy and assess if the decline is temporary or long-term in nature.

Equity Analysis

LISGRAFICA currently has an earnings per share (EPS) value of EUR-0.026. This indicates it is incurring losses instead of earning profits, so investors should carefully examine its financials to evaluate whether it has the potential to turn profitable in future. It may also be worthwhile researching reasons behind negative EPS levels and assess efforts made by LISGRAFICA to address those concerns. Finally, compare LISGRAFICA against similar industry competitors for benchmark purposes.

More news about LISGRAFICA (LIG.LS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com